- Home
- DERM vs IGA Comparison
DERM vs IGA Comparison
Compare DERM & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- IGA
- Stock Information
- Founded
- DERM 2014
- IGA 2005
- Country
- DERM United States
- IGA United States
- Employees
- DERM N/A
- IGA N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- IGA Investment Managers
- Sector
- DERM Health Care
- IGA Finance
- Exchange
- DERM Nasdaq
- IGA Nasdaq
- Market Cap
- DERM 174.7M
- IGA 149.1M
- IPO Year
- DERM 2021
- IGA N/A
- Fundamental
- Price
- DERM $6.88
- IGA $9.71
- Analyst Decision
- DERM Strong Buy
- IGA
- Analyst Count
- DERM 2
- IGA 0
- Target Price
- DERM $10.00
- IGA N/A
- AVG Volume (30 Days)
- DERM 78.2K
- IGA 42.3K
- Earning Date
- DERM 05-20-2025
- IGA 01-01-0001
- Dividend Yield
- DERM N/A
- IGA 8.93%
- EPS Growth
- DERM N/A
- IGA N/A
- EPS
- DERM N/A
- IGA N/A
- Revenue
- DERM $56,134,000.00
- IGA N/A
- Revenue This Year
- DERM $29.83
- IGA N/A
- Revenue Next Year
- DERM $54.88
- IGA N/A
- P/E Ratio
- DERM N/A
- IGA N/A
- Revenue Growth
- DERM N/A
- IGA N/A
- 52 Week Low
- DERM $3.20
- IGA $7.77
- 52 Week High
- DERM $7.84
- IGA $8.88
- Technical
- Relative Strength Index (RSI)
- DERM 52.73
- IGA 52.04
- Support Level
- DERM $6.47
- IGA $9.68
- Resistance Level
- DERM $7.15
- IGA $9.86
- Average True Range (ATR)
- DERM 0.49
- IGA 0.13
- MACD
- DERM -0.09
- IGA -0.00
- Stochastic Oscillator
- DERM 37.25
- IGA 43.10
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategy.